As a result of funding constraints on governmental agencies in the United States and other countries, coupled with the growing interest in cystic fibrosis research, occasions arise in which highly meritorious grant applications are submitted to these governmental agencies but are not funded. The Cystic Fibrosis Foundation does not intend to assume the role of the National Institutes of Health (NIH) or other governmental funding agencies elsewhere but instead wishes to ensure that the momentum in CF research is not irreversibly slowed.
Support from the Cystic Fibrosis Foundation is intended to provide for the development of preliminary data to make CF-related grant applications highly competitive at the NIH (or in review processes of governmental funding agencies in other countries).
• The application must have been reviewed by an NIH study section and presented to an institute council within 12 months of applying for CFF support.
• Applications must have been submitted to NIH as an R01 and fall within the upper 40th percentile (1- 40%). If an application has been submitted to NIH multiple times, the most recent submission must have been scored inthe upper 40th percentile to be considered.
• Unfunded resubmitted applications (A1 or other) may be submitted through this mechanism, however, may be subject to additional scrutiny.
• A project may only receive funding through the CFF/NIH-Unfunded mechanism one time. If a project has received funding through this mechanism previously, it cannot be resubmitted, even if it has gone back to the NIH (or other governmental funding agency).
Sponsor Institute/Organizations: Cystic Fibrosis Foundation
Sponsor Type: Corporate
Address: 4550 Montgomery Ave. Suite 1100 N Bethesda, MD 20814
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 01, 2025
$125,000
Affiliation: Cystic Fibrosis Foundation
Address: 4550 Montgomery Ave. Suite 1100 N Bethesda, MD 20814
Website URL: https://www.cff.org/researchers/cffnih-r01-unfunded-award
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.